PoHung Lai - Maxigen Biotech Deputy Mang

All Insiders . Taiwan . 
Stock . Maxigen Biotech . Stakeholders . Insider . PoHung Lai
1783 Stock  TWD 43.70  0.50  1.13%   

Insider

PoHung Lai is Deputy Mang of Maxigen Biotech
Phone886 3 328 7222
Webhttps://mbi-bio.com

Maxigen Biotech Management Efficiency

The company has return on total asset (ROA) of 0.0454 % which means that it generated a profit of $0.0454 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0926 %, meaning that it generated $0.0926 on every $100 dollars invested by stockholders. Maxigen Biotech's management efficiency ratios could be used to measure how well Maxigen Biotech manages its routine affairs as well as how well it operates its assets and liabilities.
Maxigen Biotech has accumulated 16.62 M in total debt with debt to equity ratio (D/E) of 1.5, which is about average as compared to similar companies. Maxigen Biotech has a current ratio of 7.65, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Maxigen Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Maxigen Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Maxigen Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Maxigen to invest in growth at high rates of return. When we think about Maxigen Biotech's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Bi ChenE Lead Electronic Co
N/A
WeiKuo HongChunghwa Telecom Co
61
Fred LaiPhytohealth Corp
N/A
Yufang WangYung Zip Chemical
N/A
YuShen ChenChunghwa Telecom Co
46
YiLi LeePhytohealth Corp
N/A
Chih HuangPhytohealth Corp
N/A
WenShun HoZinwell
N/A
Xi ChenE Lead Electronic Co
N/A
Feng HongChunghwa Telecom Co
N/A
RongShy LinChunghwa Telecom Co
56
Kevin LinPhytohealth Corp
N/A
Mao KeE Lead Electronic Co
N/A
ChingHui LinZinwell
N/A
Li YehPhytohealth Corp
N/A
YiFen HuangZinwell
N/A
Yi LiPhytohealth Corp
N/A
ILin LeePhytohealth Corp
N/A
Zhen WuE Lead Electronic Co
N/A
LiangChang ChouKinko Optical Co
N/A
ChingChi ChenKinko Optical Co
N/A
Maxigen Biotech Inc. engages in the development, manufacture, and marketing of biomedical and cosmeceutical skincare products in Taiwan and internationally. Maxigen Biotech Inc. was founded in 1998 and is based in Taoyuan, Taiwan. MAXIGEN BIOTECH is traded on Taiwan Stock Exchange in Taiwan. Maxigen Biotech (1783) is traded on Taiwan Stock Exchange in Taiwan and employs 20 people.

Management Performance

Return On Equity0.0926
Return On Asset0.0454

Maxigen Biotech Leadership Team

Elected by the shareholders, the Maxigen Biotech's board of directors comprises two types of representatives: Maxigen Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maxigen. The board's role is to monitor Maxigen Biotech's management team and ensure that shareholders' interests are well served. Maxigen Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maxigen Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
PoHung Lai, Deputy Mang
ChingTing Chen, GM Director
WanHow You, Financial Officer
Karen Lee, Sr Admin

Maxigen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Maxigen Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0926
Return On Asset0.0454
Profit Margin0.19 %
Operating Margin0.16 %
Current Valuation3.32 B
Shares Outstanding84.7 M
Shares Owned By Insiders51.89 %
Shares Owned By Institutions2.28 %
Price To Earning33.55 X
Price To Book3.24 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Additional Tools for Maxigen Stock Analysis

When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY